CT VScore+ vs FFRangio System
AI Verdict
Choose CT VScore+ if…
Choose CT VScore+ if your primary goal is to efficiently perform non-invasive, automated cardiac calcium scoring for early coronary risk assessment and population screening. This tool is ideal for streamlining the quantification of coronary artery calcification from existing ECG-gated CT images, reducing manual effort and providing comprehensive Agatston and volume scores with percentile comparisons for enhanced clinical insight.
View CT VScore+ →Choose FFRangio System if…
Choose the FFRangio System if you require real-time, wire-free, and drug-free functional assessment of coronary artery disease to guide and optimize percutaneous coronary intervention (PCI) decisions in the cath lab. This system is best suited for interventional cardiologists seeking to accurately assess the hemodynamic significance of lesions and confirm treatment efficacy without the need for invasive pressure wires or pharmacological agents.
View FFRangio System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | CT VScore+ | FFRangio System |
|---|---|---|
| Pricing | Unknown | Contact vendor for pricing information. |
| Deployment | Unknown | SaaS, on-prem, hybrid |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | 1 AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
FFRangio SystemTool B explicitly highlights an 'intuitive user interface' and 'artificial intelligence aids in quick angiogram analysis,' suggesting a streamlined experience during critical procedures. Furthermore, its 'wire-free and drug-free' approach simplifies a traditionally invasive process, directly enhancing the user's workflow and patient experience. Tool A focuses on automating reporting and reducing manual data entry, which is valuable but less directly impactful on the core procedural interaction.
Clinical Value
FFRangio SystemTool B provides 'real-time FFRangio values' and 'advanced insights to quickly optimize and confirm PCI decisions,' directly impacting interventional treatment strategies and patient outcomes during a procedure. Its 'Lesion Impact feature' and 'simulated pullback curve' offer immediate, actionable guidance for clinicians. While Tool A offers valuable automated cardiac calcium scoring for risk assessment, Tool B's direct influence on real-time therapeutic decisions provides a more immediate and profound clinical impact.
Pricing & Value
TieBoth Tool A and Tool B state 'contact for pricing,' offering no transparent pricing information. Without specific cost details or publicly available value propositions beyond their feature sets, it is impossible to conduct a head-to-head comparison on pricing or overall value.
Enterprise Readiness
CT VScore+Tool A explicitly states it is 'hipaa_compliant' and 'has_baa,' which are critical for enterprise adoption and handling Protected Health Information (PHI) in healthcare. While Tool B is FDA cleared and ISO 27001 certified for information security, its HIPAA compliance and BAA status are only noted as 'likely' or 'unknown' in the provided facts, making Tool A's compliance posture more transparent and confirmed for enterprise environments.
Innovation
FFRangio SystemTool B demonstrates greater innovation by delivering 'wire-free and drug-free 3D FFR guidance,' fundamentally transforming the traditional invasive FFR measurement process. This represents a significant advancement in interventional cardiology by eliminating the need for invasive pressure wires and drugs. Tool A, while valuable, focuses on automating an existing diagnostic process (calcium scoring) rather than introducing a paradigm shift in methodology.
Support & Docs
TieNo information regarding support services, documentation availability, or quality was provided for either Tool A or Tool B in the structured facts or readily available through web searches. Therefore, it is not possible to distinguish between the two products on this dimension.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | CT VScore+ | FFRangio System |
|---|---|---|
| Name | CT VScore+ | FFRangio System |
| Company | Canon Medical Informatics | CathWorks |
| Description | CT VScore+ is an AI-powered software application by Canon Medical Informatics that automates cardiac calcium scoring from ECG-gated, non-contrast cardiac CT images, providing Agatston and volume scores for coronary risk assessment. | The CathWorks FFRangio System delivers wire-free and drug-free 3D FFR guidance, providing accurate multi-vessel FFR results and advanced insights to quickly optimize and confirm PCI decisions for patients with coronary artery disease. |
| Key Features | Automated cardiac calcium scoring, Removes manual data entry from reporting, Generates Agatston and volume calcium scores, Highlights segmented calcium on CT images, Runs on Vitrea platform, Non-invasive evaluation of coronary artery calcified lesions, Utilizes ECG-gated, non-contrast cardiac CT images, Provides calcium percentile comparison to reference data (MESA, Hoff-Kondos) | Real-time FFRangio values at every point on the coronary tree, Simulated pullback curve differentiates functional patterns of CAD, Lesion Impact feature to assess residual ischemia, Integrated sizing tool for non-invasive lesion measurements, Intuitive user interface, Artificial intelligence aids in quick angiogram analysis, Seamless integration with cath lab boom and PACS, Eliminates the need for invasive pressure wires, drugs, or a guide catheter |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Surgical AI |
| Specialties | Cardiology, Radiology | Cardiology |
Videos
Demos, reviews, and walkthroughs featuring CT VScore+ and FFRangio System.